Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart valve showdown: which type lasts longer in patients under 70?

NCT ID NCT07168889

Knowledge-focused Sponsor: Alissa Florian Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study looked at over 3,500 patients aged 70 or younger who had mitral valve replacement surgery in Austria between 2010 and 2020. Researchers compared those who got a mechanical valve versus a biological valve to see which group lived longer and needed fewer repeat operations. The goal is to help guide surgeons in choosing the best valve type for younger patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors choose the best type of heart valve for younger patients, potentially improving long-term survival and reducing the need for repeat surgeries.
What could go wrong
This is an observational study, not a controlled trial, so results may be influenced by other factors. It only looks back at past data, so it cannot prove cause and effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

3,520 people

The number who actually took part.

Started

Jan 2010

Finished

Dec 2020

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Austria. The data included 3,520 patients aged ≤70 years who underwent mitral heart valve surgery between 1.1.2010 and 31.12.2020 in Austria.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Mitral valve surgery between 01.01.2010 and 31.12.2020 Exclusion Criteria: * concomitant procedures on other valves

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mitral valve disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

mitral valve disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Mitral valve replacement

More trials for these conditions

Other studies related to the condition(s) this trial covers.